Mariner
AMRX icon

Mariner’s Amneal Pharmaceuticals AMRX Stock Holding History

Mariner’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43M Sell
313,725
-1,829
-0.6% -$25.1K 0.01% 1000
2026
Q1 		$3.92M Sell
315,554
-29,639
-9% -$398K ﹤0.01% 1153
2025
Q4 		$4.35M Sell
345,193
-49,897
-13% -$571K 0.01% 1065
2025
Q3 		$3.95M Sell
395,090
-4,421
-1% -$39.7K 0.01% 1040
2025
Q2 		$3.23M Buy
399,511
+5,988
+2% +$45.1K ﹤0.01% 1068
2025
Q1 		$3.3M Sell
393,523
-30,768
-7% -$257K 0.01% 975
2024
Q4 		$3.36M Buy
424,291
+413,268
+3,749% +$3.47M 0.01% 955
2024
Q3 		$91.7K Buy
11,023
+469
+4% +$3.67K ﹤0.01% 3106
2024
Q2 		$67K Buy
10,554
+294
+3% +$1.87K ﹤0.01% 3013
2024
Q1 		$62.2K Sell
10,260
-4
-0% -$23 ﹤0.01% 3002
2023
Q4 		$62.3K Buy
+10,264
New +$45.7K ﹤0.01% 2920

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Mariner's AMRX Position: Q2 2026 in Review

Mariner reduced its Amneal Pharmaceuticals (AMRX) stake by 0.58% in Q2 2026, selling an estimated $25.1K and leaving 313,725 shares worth $5.43M. The position accounts for 0.01% of the portfolio, ranked #1000.

Mariner first reported a position in AMRX in Q4 2023 and has held it in 11 quarters since. 310 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Mariner held 313,725 shares of Amneal Pharmaceuticals worth $5.43M as of Q2 2026.
  • Mariner sold 1,829 Amneal Pharmaceuticals shares in Q2 2026, an estimated $25.1K.
  • Amneal Pharmaceuticals made up 0.01% of Mariner's portfolio in Q2 2026, its #1000 holding.
  • Mariner first reported a position in Amneal Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • 310 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.